Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

In reply to Olson.

de Castro G Jr, Snitcovsky IM.

Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):895-6. doi: 10.1016/j.ijrobp.2012.08.029. No abstract available.

PMID:
23452447
2.

Sequential dose-dense Doxorubicin and Ifosfamide in advanced soft-tissue sarcoma patients in an out-patient-basis schedule.

Almeida GF, Castro G Jr, Snitcovsky IM, Siqueira SA, Akaishi EH, Camargo OP, Oliveira CR, Federico MH.

Sarcoma. 2011;2011:984340. doi: 10.1155/2011/984340. Epub 2011 Jun 30.

3.

Transcriptional profile and response to neoadjuvante chemotherapy in breast cancer.

Folgueira MA, Snitcovsky IM, Del Valle PR, Katayama ML, Brentani MM, Vieira RA.

Rev Assoc Med Bras (1992). 2011 May-Jun;57(3):347-52. Review. English, Portuguese.

4.

ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation.

De Castro G Jr, Pasini FS, Siqueira SA, Ferraz AR, Villar RC, Snitcovsky IM, Federico MH.

Oncol Rep. 2011 Mar;25(3):693-9. doi: 10.3892/or.2011.1133. Epub 2011 Jan 3.

PMID:
21206986
5.

Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.

Gouvêa de Lima A, Villar RC, de Castro G Jr, Antequera R, Gil E, Rosalmeida MC, Federico MH, Snitcovsky IM.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):270-5. doi: 10.1016/j.ijrobp.2010.10.012. Epub 2010 Dec 14.

PMID:
21163585
6.

High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma.

de Castro G Jr, Snitcovsky IM, Gebrim EM, Leitão GM, Nadalin W, Ferraz AR, Federico MH.

Eur Arch Otorhinolaryngol. 2007 Dec;264(12):1475-82. Epub 2007 Jul 21.

PMID:
17643256
7.

Intraperitoneal chemotherapy for ovarian cancer.

de Castro G Jr, Snitcovsky IM, Federico MH.

N Engl J Med. 2006 Apr 13;354(15):1641-3; author reply 1641-3. No abstract available.

PMID:
16615184
8.

Gene expression profile associated with response to doxorubicin-based therapy in breast cancer.

Folgueira MA, Carraro DM, Brentani H, Patrão DF, Barbosa EM, Netto MM, Caldeira JR, Katayama ML, Soares FA, Oliveira CT, Reis LF, Kaiano JH, Camargo LP, Vêncio RZ, Snitcovsky IM, Makdissi FB, e Silva PJ, Góes JC, Brentani MM.

Clin Cancer Res. 2005 Oct 15;11(20):7434-43.

9.

Ras activation is associated with vitamin D receptor mRNA instability in HC11 mammary cells.

Rozenchan PB, Folgueira MA, Katayama ML, Snitcovsky IM, Brentani MM.

J Steroid Biochem Mol Biol. 2004 Sep;92(1-2):89-95.

PMID:
15544934
10.

Molecular targets of 1,25(OH)2D3 in HC11 normal mouse mammary cell line.

Katayama ML, Pasini FS, Folgueira MA, Snitcovsky IM, Brentani MM.

J Steroid Biochem Mol Biol. 2003 Jan;84(1):57-69.

PMID:
12648525
11.

Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells: a mini review.

Bortman P, Folgueira MA, Katayama ML, Snitcovsky IM, Brentani MM.

Braz J Med Biol Res. 2002 Jan;35(1):1-9. Review.

Supplemental Content

Loading ...
Support Center